{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:39:53Z","timestamp":1768880393387,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.antiviral.2016.12.015","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T09:02:04Z","timestamp":1482829324000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox"],"prefix":"10.1016","volume":"139","author":[{"given":"Ryan","family":"Crump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-0667","authenticated-orcid":false,"given":"Maria","family":"Korom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1079-0988","authenticated-orcid":false,"given":"Scott","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.12.015_bib1","first-page":"319","article-title":"Variable resistance to ectromelia (mousepox) virus among genera of Mus","volume":"127","author":"Buller","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.015_bib2","series-title":"The Mouse in Biomedical Research","author":"Buller","year":"2007"},{"key":"10.1016\/j.antiviral.2016.12.015_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2010.10.021","article-title":"Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy","volume":"409","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.12.015_bib4","article-title":"Preparation of cell cultures and vaccinia virus stocks","author":"Earl","year":"2001","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.antiviral.2016.12.015_bib5","series-title":"Guidance for Industry. Animal Models - Essential Elements to Address Efficacy under the Animal Rule","author":"FDA","year":"2009"},{"key":"10.1016\/j.antiviral.2016.12.015_bib6","series-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.antiviral.2016.12.015_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.015_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2012.02.005","article-title":"Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox","volume":"94","author":"Parker","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.015_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2014.08.003","article-title":"Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus","volume":"111","author":"Parker","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.015_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/135965350801300703","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001","volume":"13","author":"Parker","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.12.015_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2008.11.015","article-title":"Mousepox in the C57BL\/6 strain provides an improved model for evaluating anti-poxvirus therapies","volume":"385","author":"Parker","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.12.015_bib12","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"Parker","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.12.015_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model","volume":"77","author":"Parker","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.12.015_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/v3010047","article-title":"Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.12.015_bib15","first-page":"517","article-title":"Virus excretion in smallpox 1","author":"Sarkar","year":"1973","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2016.12.015_bib16","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus","volume":"85","author":"Smith","year":"2011","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:54:10Z","timestamp":1658278450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":16,"alternative-id":["S0166354216303370"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}